From: Identifying differential correlation in gene/pathway combinations
Affy HGU95 ID | Gene symbol | KEGG ID | Pathway description | S GPC | p |
---|---|---|---|---|---|
39637_at | SLC26A2 | 00300 | Lysine biosynthesis | 0.928 | <1e-04 |
39799_at | FABP5 | 00300 | Lysine biosynthesis | 0.829 | <1e-04 |
39794_at | USP8 | 00300 | Lysine biosynthesis | 0.824 | <1e-04 |
40773_at | MYL5 | 00300 | Lysine biosynthesis | 0.82 | <1e-04 |
40027_at | ATP5S | 00300 | Lysine biosynthesis | 0.814 | 1e-04 |
32001_s_at | PCSK6 | 04742 | Taste transduction | 0.807 | <1e-04 |
32001_s_at | PCSK6 | 00600 | Sphingolipid metabolism | 0.799 | <1e-04 |
32001_s_at | PCSK6 | 05110 | Cholera – Infection | 0.798 | 1e-04 |
41275_at | E2F5 | 00300 | Lysine biosynthesis | 0.798 | 3e-04 |
32001_s_at | PCSK6 | 00604 | Glycosphingolipid biosynthesis – ganglioseries | 0.786 | <1e-04 |
32001_s_at | PCSK6 | 00061 | Fatty acid biosynthesis | 0.771 | <1e-04 |
32001_s_at | PCSK6 | 00290 | Valine, leucine and isoleucine biosynthesis | 0.771 | <1e-04 |
39945_at | FAP | 00300 | Lysine biosynthesis | 0.768 | 6e-04 |
32001_s_at | PCSK6 | 03060 | Protein export | 0.765 | <1e-04 |
38571_at | FGFR1OP | 04740 | Olfactory transduction | 0.76 | <1e-04 |
32001_s_at | PCSK6 | 00190 | Oxidative phosphorylation | 0.751 | <1e-04 |
38571_at | FGFR1OP | 00440 | Aminophosphonate metabolism | 0.749 | <1e-04 |
40176_at | TRIM27 | 00625 | Tetrachloroethene degradation | 0.742 | <1e-04 |
38571_at | FGFR1OP | 04630 | Jak-STAT signaling pathway | 0.739 | <1e-04 |
38571_at | FGFR1OP | 04020 | Calcium signaling pathway | 0.737 | <1e-04 |
38571_at | FGFR1OP | 00150 | Androgen and estrogen metabolism | 0.734 | <1e-04 |
38571_at | FGFR1OP | 04930 | Type II diabetes mellitus | 0.733 | <1e-04 |
32001_s_at | PCSK6 | 00930 | Caprolactam degradation | 0.732 | 1e-04 |
38571_at | FGFR1OP | 04340 | Hedgehog signaling pathway | 0.73 | 3e-04 |
38571_at | FGFR1OP | 00860 | Porphyrin and chlorophyll metabolism | 0.728 | 2e-04 |
32001_s_at | PCSK6 | 00903 | Limonene and pinene degradation | 0.728 | <1e-04 |
38571_at | FGFR1OP | 04650 | Natural killer cell mediated cytotoxicity | 0.724 | 2e-04 |
38571_at | FGFR1OP | 04810 | Regulation of actin cytoskeleton | 0.721 | 1e-04 |
38571_at | FGFR1OP | 01510 | Neurodegenerative Disorders | 0.721 | <1e-04 |
40925_at | C7orf44 | 00300 | Lysine biosynthesis | 0.72 | 1e-04 |
38571_at | FGFR1OP | 04660 | T cell receptor signaling pathway | 0.719 | <1e-04 |
861_g_at | MSH2 | 03020 | RNA polymerase | 0.713 | <1e-04 |
38571_at | FGFR1OP | 00903 | Limonene and pinene degradation | 0.712 | <1e-04 |
38571_at | FGFR1OP | 00290 | Valine, leucine and isoleucine biosynthesis | 0.711 | 2e-04 |
38571_at | FGFR1OP | 04920 | Adipocytokine signaling pathway | 0.71 | <1e-04 |
38571_at | FGFR1OP | 00930 | Caprolactam degradation | 0.708 | 0.0013 |
32001_s_at | PCSK6 | 00471 | D-Glutamine and D-glutamate metabolism | 0.707 | <1e-04 |
38571_at | FGFR1OP | 00140 | C21-Steroid hormone metabolism | 0.706 | 1e-04 |
38571_at | FGFR1OP | 00562 | Inositol phosphate metabolism | 0.704 | <1e-04 |
38571_at | FGFR1OP | 00604 | Glycosphingolipid biosynthesis – ganglioseries | 0.702 | 7e-04 |